<p>Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin</p>

Abstract

Background and Aim: Flibanserin (FLB) is a multifunctional serotonergic agent used for treating hypoactive sexual desire disorder in premenopausal women via oral administration. FLB has a reported limited oral bioavailability of 33% that could be attributed to the drug's first-pass metabolism. In addition, FLB has a pH-dependent solubility that could be a challenging factor for drug dissolution in the body neutral fluid, and consequently, absorption via mucosal barriers. Thus, this work aims at investigating the potential of utilizing nanostructured lipid carriers (NLCs) to overcome the aforementioned drawbacks and to enhance nose-to-brain drug delivery. Methods: Box-Behnken design was applied to explore the impact of solid lipid % (SL%, X 1), liquid lipid % (LL%, X 2), and sonication time (ST, X 3) on particle size. The optimized NLC formulation was characterized and incorporated into gellan gum in situ gel. The prepared gel was subjected to in vitro drug release, in vivo pharmacokinetic performance, and histopathological assessment in rats. Results: Statistical analysis revealed a significant negative effect for both SL% and ST on NLCs size. In contrast, a significant positive effect was observed for the LL%. The optimized formulation showed spherical shape with vesicular size of 114.63 nm. The optimized FLB-NLC in situ gel exhibited adequate stability and enhanced in vitro release compared to raw FLB control gel. The plasma and brain concentrations of the drug after nasal administration in rats increased by more than 3-6-fold, respectively, compared to raw FLB in situ gel. In addition, the histopathological studies revealed the absence of any pathological signs. Conclusion: The aforementioned results highlight the safety of FLB-NLC in situ nasal gel and its potential to improve the drug bioavailability and brain delivery.

RETRACTED: Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans

“…Recently, various topically applied nanocarrier systems have been developed, including lipid based nanocarriers and polymer based nanocarriers, due to their unique advantages and great versatility as compared to conventional formulations [ 13 , 14 , 15 , 16 , 17 ]. In one of the studies, a nanosponge system was found to confine the drug into the pores of this system that showed a good availability of drugs, enhanced skin permeability and extended retention time at the site of application [ 5 ].…”

Preparation of NLCs-Based Topical Erythromycin Gel: In Vitro Characterization and Antibacterial Assessment

“…EM-NLCs-opt and EM-NLCs-opt-IG4 showed significantly higher release of EM due to the increase in the solubility of EM in the presence of the lipid and surfactant. The drug release from EM-IG was found to be significantly low due to the poor solubility of EM, high viscosity, and formation of insoluble gel matrix hindering the release of EM in STF media [ 45 ]. The release data of the EM-NLCs-opt-IG4 were fitted in different kinetic models to determine the best fit model.…”

Wasp venom peptide improves the proapoptotic activity of alendronate sodium in A549 lung cancer cells

“…This could be owing to the cavitation forces developed by the ultrasonic waves of the sonicator. These forces might cause particle size reduction by virtue of possible fractionation of the agglomerated nanoconjugate clusters [ 42 , 43 ]. A minimized particle size of the prepared ALS-MP formula was achieved as a result of the application of experimental design in drug formulation.…”